Transdermal PGE-1 Patch

Transdermal PGE-1 Patch

In September 2016, AngioSoma, Inc. with its Chairman Emeritus David P. ‘Doc‘ Summers PhD filed 2 provisional U.S. Patents and 2 non-provisional U.S. Patents (announced October 11, 2016 in a press release entitled ‘AngioSoma, Inc. Files 3 New Patent Applications on Liprostin™‘; notice correction to 4 patents from 3 referenced in press release) for a: